A new rheumatoid arthritis pill from Eli Lilly and Incyte beat out placebo in a pivotal trial, the first late-stage success for a drug the companies hope can carve out a space in a crowded market.

…read more

Source: Lilly and Incyte’s oral arthritis drug aces its first Phase III test


0 No comments